Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Background: Cholinesterase inhibitors produce small improvements in cognitive and global assessments in Alzheimer's disease. We aimed to determine whether donepezil produces worthwhile improvements in disability, dependency, behavioural and psychological symptoms, carers' psychological wellbeing, or...
| Publicado en: | Lancet Vol. 363; no. 9427; pp. 2105 - 2116 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Lancet
6/26/2004
|
| Acceso en línea: | Ver este registro en EBSCOhost |